Our Platform
Aigon View
Uncovering non visible micro-infiltrations
Aigon View is able to reveal what current medical imaging cannot yet show: the micro-infiltration zone of solid tumors. This zone represents the microscopic spread of cancer cells beyond the visible tumor margins. While clinicians currently rely on imaging sequences that capture only the macro-anatomical tumor, Aigon View analyzes the physiological fingerprint of the tissue to reconstruct the invisible.
Aigon Map
Forecasting metastases development
Adding patient's genomic sequencing data, Aigon Map is able to return the probability that the tumor will develop metastases to different organs. By combining the sequencing of normal and altered genes, their expression profiles, and imaging data (MRI, CT, PET), our model predicts the probability of metastases development. This can have a relevant impact on different clinical approaches.
Aigon Care
Predicting drugs effectiveness
Aigon Care predicts how individual cancer patients are likely to respond to specific immunotherapy drugs before treatment starts. Aigon Care enhances Precision Oncology, by helping clinicians select the right therapy, for the right person, at the right time. This is critical because immunotherapies are among the most expensive oncology treatments and often deliver low response rates.